Trupanion (NASDAQ:TRUP) CFO Fawwad Qureshi Sells 6,111 Shares

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total transaction of $183,391.11. Following the transaction, the chief financial officer owned 4,230 shares in the company, valued at approximately $126,942.30. The trade was a 59.09% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Trading Down 5.2%

Shares of TRUP opened at $30.19 on Thursday. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of 56.96, a PEG ratio of 2.15 and a beta of 1.39. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The business’s fifty day moving average is $26.76 and its 200-day moving average is $26.00. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $46.98.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same period last year, the company earned $0.22 earnings per share. The business’s quarterly revenue was up 11.1% on a year-over-year basis. Equities analysts anticipate that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on TRUP shares. Piper Sandler lowered Trupanion from an “overweight” rating to a “neutral” rating and reduced their target price for the company from $45.00 to $32.00 in a report on Wednesday. Weiss Ratings raised shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 12th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research note on Wednesday, July 15th. Finally, Stifel Nicolaus boosted their price objective on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Thursday, August 20th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $39.20.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of TRUP. Royal Bank of Canada boosted its position in Trupanion by 60.6% in the first quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after purchasing an additional 11,233 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Trupanion by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after buying an additional 858 shares in the last quarter. Millennium Management LLC raised its stake in shares of Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after acquiring an additional 113,490 shares during the period. Invesco Ltd. grew its position in Trupanion by 35.1% in the 2nd quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after acquiring an additional 48,781 shares during the last quarter. Finally, Gabelli Funds LLC purchased a new stake in shares of Trupanion in the second quarter valued at approximately $249,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.